Fri, Nov 22, 2024 | Updated 01:32 IST
Sputnik V meets primary endpoint of safety in phase 2 clinical trial in India
Jan 12, 2021
Hyderabad (Telangana) [India], January 12 : Dr Reddy's Laboratories has said that independent Data and Safety Monitoring Board (DSMB) reviewed the safety data from...
Sun Pharma initiates phase two clinical trial on AQCH as potential treatment for COVID-19 patients
Jun 05, 2020
Mumbai (Maharashtra) [India], June 5 : Sun Pharmaceutical Industries has started phase two clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for the treatment...
Indian Immunologicals signs MoA with ICMR for clinical development of Zika vaccine
Sep 12, 2024
As per the MoA, the Indian Council of Medical Research (ICMR) will fund the Phase I clinical trial costs, including the costs relating to...
Three COVID-19 vaccines at clinical trial stage in India: ICMR DG
Sep 15, 2020
New Delhi [India], September 15 : Three COVID-19 vaccines are at a clinical trial stage in the country and two indigenous vaccine candidates have...
Narayana Health initiates Phase II Clinical Trial of CAR-T
Oct 20, 2022
Bengaluru (Karnataka) [India], October 20 (ANI/NewsVoir): Narayana Health, one of the leading healthcare chain in India, today announced that they have offered support to...
COVID-19: MSN Laboratories initiates Phase III clinical trial of Molnupiravir
May 26, 2021
New Delhi [India], May 26 : MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of Molnupiravir capsules for the treatment of...
AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin
Dec 24, 2020
PGI Rohtak to start phase-2 trial of Bharat Biotech's Covid-19 vaccine
Sep 08, 2020
Submit previous trial data for Covaxin before rolling out phase III: Drug regulator to Bharat Biotech
Oct 10, 2020
COVAXIN shows high safety, immunogenicity during phase 1 clinical trial: Lancet journal
Jan 22, 2021
Emergency use of vaccine is based on safety, immunogenicity data, says ICMR chief
Jan 05, 2021
Glenmark announces top-line results from phase 3 clinical trial of Favipiravir in patients with mild to moderate COVID-19
Jul 23, 2020
Related Videos
No Result Found